Testosterone Patch Benefits Women with Low Sexual Desire

	Tweet

Novel research published in the current issue of The Journal of Sexual Medicine supports the claim that women with hypoactive sexual desire disorder or HSDD (persistent or recurrent deficiency and/or absence of sexual fanatasies/thoughts, and/or desire for, or receptivity to, sexual activity, which causes personal distress) show noted improvement in sexual desire and sexual function following low dose testosterone treatment.

Two randomized double-blind, placebo controlled trials in surgically postmenopausal (uterus and ovaries removed) women with HSDD demonstrated that transdermal testosterone patch treatment resulted in significant improvements in the frequency of satisfying sexual activity and sexual desire, as well as a decrease in sexual distress.

A total of 132 participants from the 2 trials were interviewed after a 6-month treatment period regarding their experience with the treatment. Results revealed a significant increase in frequency of satisfying sexual activity and sexual desire based on women experiencing the treatment as beneficial. Those women had an average increase in sexual activity of 4.4 times per 4 weeks. In contrast, women who did not experience a benefit had only a 0.5 increase in activity per 4 weeks.

“More women on testosterone experienced a meaningful benefit (52 percent vs. 31 percent) and, in fact, the odds of experiencing a meaningful benefit on testosterone were 2.4 times greater than that of placebo,” says Sheryl Kingsberg, principal author of the study. Since the women were also able to judge for themselves whether or not the treatment was beneficial, those who experienced benefit were interested in continuing treatment.

“These findings not only confirm the clinical effectiveness of transdermal testosterone, but provide benchmarks for the degree of improvement in sexual function that all future therapies for this disorder should try to attain,” says Jan Shifren, co-author of the study.

“This is an especially relevant clinical study in the field of sexual medicine,” said Dr. Irwin Goldstein, Editor-in-Chief of The Journal of Sexual Medicine. “These important data reinforce the positive value that treatment with the low dose testosterone patch can bring to the quality-of-life of surgically post-menopausal women with HSDD.”

The manuscript is published in The Journal of Sexual Medicine. Media who wish to receive a PDF of the article may contact .

Dr. Sheryl Kingsberg is an Associate Professor and Chief, Division of Behavioral Medicine in the Department of Obstetrics and Gynecology at MacDonald Women’s Hospital, Case Western Reserve University School of Medicine.

Dr. Jan Shifren is Associate Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School, Boston, MA.

Dr. Irwin Goldstein is Editor-in-Chief of The Journal of Sexual Medicine; Director, Sexual Medicine at Alvarado Hospital, San Diego, California; Director, San Diego Sexual Medicine, San Diego, California; and Clinical Professor of Surgery, University of California, San Diego.

Drs. Kingsberg, Shifren and Goldstein are available for questions and interviews. To arrange for a telephone interview, please contact .

RELATED STORIES:
Syphilis back with a vengeance in China   New Study Explores Role of Sexual, Social Behaviors in Seniors’ Well-Being   Sexual lyrics in popular songs linked to early sexual experiences   Increased responsibility could lead to decreased sexual activity among women   Researchers Find Vibrator Use to be Common, Linked to Sexual Health   Obesity Delays Puberty in Boys   Teens Need to See Their Doctors More Often   Abused girls may have higher risk of heart disease, stroke as adults   The rise and fall of Viagra   Impotence: Causes and Treatment   Bisexual men: When sexual health requires stealth   More STDs for Older Widowers in ED Drug Era   Intoxication important in determining when some men commit sexual aggression   Pitt study shows linkage between teen girls’ weight and sexual behavior   Long-term use won’t cut extract’s erectile effects

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]